Diabetes Market Research Reports & Industry Analysis
The global prevalence of diabetes has risen steadily, driving significant demand for devices and drugs to monitor and treat the condition. While traditional treatments continue to dominate the market, new technologies and therapeutics are gaining increasing importance. For in-depth analysis of the global diabetes devices and drugs market, explore the research collection available on MarketResearch.com, featuring hundreds of authoritative reports from leading firms.
New Diabetes Market Data and Analysis
- Uncover vital insights on key segments like glucose monitors, insulin pumps, insulin pens, syringes, and more.
- Gain valuable insights, including diabetes device market size, growth projections, and drivers and challenges.
- Discover new technological innovations, industry trends, and competitor strategies to stay ahead of the curve.
Benefit from Unparalleled Industry Expertise
With over two decades of experience in the field of market research, MarketResearch.com is a trusted choice for top investment banks, management consulting firms, and Fortune 500 multinational companies. Use our insights to make better informed decisions regarding market expansion opportunities, upcoming product launches, and marketing tactics. Browse our list of diabetes market research reports to get started today.
Diabetes Industry Research & Market Reports
-
The 2026-2031 World Outlook for Diabetes Therapeutics
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Diabetes Monitoring and Diagnostic Devices
... country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... Read More
-
The 2026-2031 World Outlook for Diabetes Injection Pens for Type I Diabetes
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2026-2031 World Outlook for Diabetes Devices
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Continuous Glucose Monitoring
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
Non-Insulin Diabetes Therapeutics
... at a CAGR of 9.1% over the analysis period 2024-2030. DPP4 Inhibitors, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$37.9 Billion by the end of ... Read More
-
Type 1 Diabetes
... at a CAGR of 5.4% over the analysis period 2024-2030. Insulin Pen, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$9.4 Billion by the end of ... Read More
-
Insulin Patch Pumps
... at a CAGR of 9.8% over the analysis period 2024-2030. Basal & Bolus, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$1.4 Billion by the end ... Read More
-
Insulin Storage Devices
... at a CAGR of 7.5% over the analysis period 2024-2030. Battery Operated Devices, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$996.0 Million by the end ... Read More
-
Diabetes Diagnostics
... CAGR of 8.5% over the analysis period 2024-2030. Test Strips, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$14.7 Billion by the end of the analysis ... Read More
-
Self-Care Medical Devices
... at a CAGR of 4.5% over the analysis period 2024-2030. Blood Glucose Monitors, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$34.8 Billion by the end ... Read More
-
Type 2 Diabetes Mellitus Treatment
... Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Insulin, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$28.4 Billion by ... Read More
-
Artificial Intelligence (AI) in Diabetes Management
... reach US$21.4 Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More
-
Diabetes Monitoring Devices
... at a CAGR of 6.4% over the analysis period 2024-2030. Self-Monitoring Blood Glucose Devices, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$11.0 Billion by the ... Read More
-
Smart Insulin Pens and Pumps
... Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Pumps, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$7.9 Billion by ... Read More
-
Blood Glucose Monitoring Systems
... 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Self-Monitoring, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$21.4 Billion by the end ... Read More
-
Insulin Delivery Systems
... at a CAGR of 3.2% over the analysis period 2024-2030. Syringes, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$7.0 Billion by the end of the ... Read More
-
Digital Diabetes Management
... at a CAGR of 18.6% over the analysis period 2024-2030. Devices, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$46.7 Billion by the end of the ... Read More
-
Diabetes Injection Pens
... at a CAGR of 5.7% over the analysis period 2024-2030. Insulin Pens, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$8.2 Billion by the end of ... Read More
-
Continuous Glucose Monitoring Systems
... 2030, growing at a CAGR of 15.9% over the analysis period 2024-2030. Sensors, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$5.4 Billion by the end ... Read More
-
Pediatric Diabetes Therapeutics
... at a CAGR of 12.2% over the analysis period 2024-2030. Type 1, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$11.3 Billion by the end of ... Read More
-
Diabetes Associated Ophthalmic Treatment
... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Diabetic Ophthalmic Drugs, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.9 Billion by ... Read More
-
Diabetes Care Devices
... at a CAGR of 10.3% over the analysis period 2024-2030. Blood Glucose Monitoring Devices, one of the segments analyzed in the report, is expected to record a 12.5% CAGR and reach US$51.1 Billion by the ... Read More
-
Autoinjectors
... 15.9% over the analysis period 2024-2030. Disposable Autoinjectors, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$101.1 Billion by the end of the analysis period. Growth ... Read More
-
Artificial Pancreas Device Systems
... 2030, growing at a CAGR of 18.8% over the analysis period 2024-2030. Threshold Suspended Device Systems, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$1.2 Billion ... Read More
Research Assistance
